Ahead of print

>

Rethinking obstructive sleep apnoea: integrating precision medicine and technological advances across the lifespan

>

Co-morbid insomnia and sleep apnea and cardiovascular consequences: is the whole greater than each part?

>

Obstructive sleep apnea in obesity: traditional and emerging treatment strategies

>

Approach to obstructive sleep apnea in children from a cardiovascular perspective

>

New bio signals in sleep studies scoring

>

Artificial intelligence applied to sleep medicine

>

Pleural effusion: a challenge with multiple approaches

>

Editorial: Pulmonary hypertension

>

Relevance of Systems Biology to Respiratory Medicine

>

Bronchiectasis: From Neglected to a Trendy Airway Disease

>

Pulmonary Fibrosis in the New Millennium

>

New Environmental Hazards for Our Lungs

>

BRN Reviews: New editor’s view

>

Once upon a time…

>

Editorial

>

Editor’s note

>

Skeletal Muscle Dysfunction: From Chronic Respiratory Disease to Critically Ill Patients

>

Where BRN Reviews is One and a Half Years After its Launch…

>

Editorial

>

Editorial

>

Underlying Mechanisms of Cardiovascular Disease in Chronic Obstructive Pulmonary Disease

>

Editorial

>

Fibrotic ILDs: translating research advances into clinical practice

>

Tuberculosis at a crossroads: rethinking detection, management, and innovation

>

Hot Topics in Bronchial Asthma

>

Foreword

>

After a Five-Year Term…

>

Featuring Characteristics of Chronic Obstructive Pulmonary Disease, Procalcitonin and Lower Tract Infections and Inert Gas Studies

>

Genes, Telomeres, Allergies and Biomarkers, Key Pathogenic Clues of Chronic Respiratory Diseases

>

New insights into chronic respiratory disorders

>

List of reviewers 2017

>

Women, Small Airways, Lung Function, Imaging and Biologics, Related to Chronic Respiratory Problems …and Good News for 2018

>

Small Airways Disease, Emphysema, Lung Cancer, Multi-Morbidities and Therapeutic Trials…

>

More… about chronic obstructive airway and pulmonary vascular disorders

>

Chronic Respiratory Diseases, Lung Microbiome and Imaging Novelties

>

List of reviewers 2015/2016

>

Editorial

>

Editorial

>

T2-Inflammation-Induced Asthma, Chronic Obstructive Pulmonary Disease Strategies and Anaesthesia-Induced Lung Abnormalities

>

Quality requirements to establish a successful lung cancer screening program

>

Insights Into the Pathobiology of Pulmonary Hypertension

>

Facets of chronic obstructive airways diseases

>

From the Worldwide Impact of a Global Strategy for Asthma (GINA) to the Tragic Effects of Sea Oil Spill

>

Genetics of fibrosing interstitial lung diseases

>

Genetic Risk for Developing Chronic Obstructive Pulmonary Disease

>

Phenotyping Asthma: Linking Clinical Features to Biomolecular Pathways

>

Acute bronchitis

>

Prediction Models in Chronic Obstructive Pulmonary Disease – Informing Practice and Improving Research

>

Pleural effusion: diagnostic approach

>

Women and Chronic Obstructive Pulmonary Disease

>

Long-Acting Inhaled Bronchodilators: The Mainstay of COPD Management

>

Global Initiative for Chronic Obstructive Lung Disease (GOLD) Revisions 2001-2017: Historical and Critical Perspective

>

Cellular Mechanisms in the Pathogenesis of Idiopathic Pulmonary Fibrosis

>

Bronchiectasis in pediatrics

>

Insights into Chronic Obstructive Pulmonary Disease Epidemiology, Phenotypes and Outcomes from SPIROMICS

>

Beyond T2-inflammation: What Does the Future Hold for Severe Asthma?

>

The Case of Sleep Apnoea and Cardiovascular Events

>

What the First Issue of 2017 BRN Reviews Features…

>

The Impact of the Global Initiative for Asthma (GINA): Compass, Concepts, Controversies and Challenges

>

Integrating Genetics and Omics to Understand Chronic Obstructive Pulmonary Disease

>

Differential Features of COPD in China

>

Respiratory Effects of Exposure to Environmental Noise Levels and Noise Annoyance

>

The Copenhagen City Heart Study Experience and its Key Contributions to Chronic Obstructive Pulmonary Disease

>

Tuberculosis screening in vulnerable populations

>

Management of Bronchiectasis in Adults

>

Novelties in Pulmonary Hypertension Secondary to Left Heart Disease

>

Current strategies for the diagnosis of pulmonary embolism

>

Bronchiectasis: What We Don’t Know Yet But Should

>

Cellular Biomarkers of Rejection in Lung Transplant: The Usefulness of Eosinophil and Lymphocyte Counts

>

A semantic approach to chronic cough

>

Asthma and Air Pollution. Where Are We?

>

Air pollution and lung cancer

>

Quality standards for cryobiopsy

>

Clinical, Mechanistic and Therapeutic Topics and Chronic Obstructive Airways Disorders: On and On…

>

Contributions of the Body Mass Index, Obstruction, Dyspnea and Exercise Capacity or BODE index to Chronic Obstructive Pulmonary Disease

>

A New Therapeutic Approach Based on a Reinterpretation of Asthma Control

>

Eosinophilia and Chronic Airway Diseases

>

Long-acting Bronchodilators in COPD Management: One or Two?

>

Small Airways Disease in Chronic Obstructive Pulmonary Disease: A 50 Years History

>

Types of Respiratory Intermediate Care Units

>

Primary ciliary dyskinesia

>

Selection of Patients for Admission to the Respiratory Intermediate Care Unit

>

The Lung-Gut-Cross Talk in Chronic Airways Diseases

>

Lung Function Trajectories: a New Framework to Understand Adult Chronic Respiratory Diseases

>

Asthma-Chronic Obstructive Pulmonary Disease Overlap in Spain: Anything Special?

>

Diagnostic and Therapeutic Challenges for Patients with Pulmonary Hypertension due to Lung Diseases

>

New insights in excessive dynamic airway collapse (EDAC) and tracheobronchomalacia

>

Bronchiectasis Exacerbations: Clinical Relevance and Management

>

The Etiological Screening of Bronchiectasis

>

Mechanotherapeutics for the Treatment of Idiopathic Pulmonary Fibrosis

>

The expanding importance of tissue sample analysis for biomarker testing in non-small cell lung cancer management and survival

>

Triple Therapy for COPD: Historical Perspective and Current Controversies

>

Biomarkers of malignancy in pleural effusions

>

Sleep Apnoea and Cancer: Is There a Relationship?

>

Inhaled Treatments for Bronchial Asthma: Molecules and Devices

>

The Canadian Cohort Obstructive Lung Disease (CanCOLD): New Insights for Primary Care Application

>

New Occupational Exposures with Respiratory Effects

>

Impact of Chronic Cough on Quality of Life

>

Mechanisms of the Development of Allergy (MeDALL) Study: A Systems Medicine Approach to Understand Allergic Diseases

>

Novelties on treatment of hemodynamically stable pulmonary embolism from 2019 to present

>

Gastroesophageal Reflux in Lung Transplantation

>

Community-acquired pneumonia: risk factors, prognosis, microbial etiology, treatment, and prophylaxis

>

The Impact of Emphysema on Chronic Obstructive Pulmonary Diseases

>

Idiopathic Pulmonary Fibrosis: What Is the Best Treatment?

>

Which Are The Most Relevant Comorbidities In COPD?

>

Idiopathic Pulmonary Fibrosis: Clinical Behavior, Pathogenic Mechanisms and Therapeutic Approach

>

The Debate About the Use of Long-Acting Inhaled ß-agonists in Asthma

>

The Childhood of Adult-Onset Asthma and the Asthma/Chronic Obstructive Pulmonary Disease Overlap

>

Management of Chronic Obstructive Pulmonary Disease: A Personalized Interpretation of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) – ABCD Recommendations

>

Tuberculosis without microbiological confirmation

>

The Use of Home Noninvasive Ventilation in Chronic Hypercapnic Chronic Obstructive Pulmonary Disease

>

The Challenge of Obesity and Asthma in Children and Adolescents

>

Research Needs on Physical Activity and COPD: Bridging the Gap between Knowledge and Behaviour

>

The PLATINO Study: Contributions to COPD Knowledge

>

The Many Faces of Chronic Obstructive Pulmonary Disease: Moving Towards Precision Medicine

>

Small Airways Disease and Asthma Management: Is there a Connection?

>

Current management in hypersensitivity pneumonitis

>

Non-invasive Biomarkers of Idiopathic Pulmonary Fibrosis and Lung Cancer

>

When interstitial lung diseases associates pulmonary hypertension, what to do?

>

Practising Personalized Medicine in Asthma

>

Vegetation, Air Pollution, and Asthma and Allergy: A Narrative Review

>

Bronchiectasis and Quality of Life; Which is the Best Questionnaire?

>

Advances in Chronic Obstructive Pulmonary Disease Imaging

>

Exercise Pulmonary Hypertension

>

Management and Therapy for Pulmonary Hypertension: 2016 Update

>

Mucolytics/antioxidants: When Are They Useful?

>

3D Printed tracheobronchial stents: personalized medicine in silicone

>

Advances in thoracic surgery: from diagnosing nodules to treating locally advanced lung cancer

>

Objective measurement of cough

>

Use of Bacteriophages in Lung Transplantation

>

Corticosteroids and Pneumonia in COPD: A Dual Effect?

>

Health-Related Quality of Life in Chronic Obstructive Pulmonary Disease

>

Pulmonary Tuberculosis Management: 2015 Update

>

Role of the TSLP and its Receptor in the Treatment of Asthma

>

Main Procedures in the Intermediate Respiratory Care Units

>

Ambulatory management of acute pulmonary embolism

>

Challenging Multi-Morbidities: Obstructive Sleep Apnoea and Cancer

>

A holistic approach to the treatment of drug-resistant tuberculosis

>

Ultrasound and pleural pathology: a great ally

>

Chronic pulmonary aspiration in children

>

Biologics for Chronic Obstructive Pulmonary Disease: Present and Future

>

Telomere-Related Gene Mutations and Lung Diseases: Pulmonary Fibrosis, Emphysema and Lung Cancer

>

The Clinical Relevance of Periostin in Asthma

>

Bronchiectasis in Chronic Obstructive Airway Disease: More than a Comorbidity?

>

Hospital-acquired pneumonia: risk factors and prognosis, microbial etiology, treatment, and prophylaxis

>

Comprehensive Care in Pulmonary Fibrosis

>

GOLD Reports on Chronic Obstructive Pulmonary Disease (COPD): Evolutions, Revolutions and Controversies

>

Chronic Respiratory Abnormalities in the Multi-Morbid Frail Elderly

>

Aging and Chronic Respiratory Diseases: Novel Mechanisms

>

Use of Biomarkers in Chronic Obstructive Pulmonary Disease: Clinical Implications

>

Sleep Apnoea and Early Antecedents of Adult Disease

>

Chronic Obstructive Pulmonary Disease Exacerbations: Current Controversies

>

Microbiome in Chronic Lung Diseases

>

Obesity Hypoventilation Syndrome: New Insights

>

The role of interventional pulmonology in the diagnosis and management of undiagnosed pleural effusions

>

The role of antimicrobial stewardship in the management of tuberculosis

>

Lung Cancer Management: where are we in 2017?

>

Interventional therapies in acute pulmonary embolism

>

Phosphodiesterase Inhibitors: Present and Future

>

Pros and Cons of Inhaled Corticosteroids Withdrawal in Chronic Obstructive Pulmonary Disease

>

Optimizing treatment success in lung cancer: the role of functional testing

>

Asthma in the Elderly: Systematic Approach to Improve the Prognosis

>

Exercise and chronic pulmonary diseases in pediatrics

>

Exercise testing to evaluate therapeutic interventions in chronic respiratory diseases

>

Chronic Obstructive Pulmonary Disease and Bronchodilator Response: Does it Matter?

>

Can the Lung be Obese? The Effects of Bariatric Surgery on Lung Function and Imaging

>

The Natural History of COPD: Beyond Fletcher and Peto

>

Pneumonia in Patients with Chronic Obstructive Pulmonary Disease

>

Lung Cancer and Chronic Obstructive Pulmonary Disease: Role for Screening with Low Dose CT

>

Aspiration pneumonia: epidemiology, risk factors, etiology, diagnosis, treatment, prophylaxis, and prognosis

>

The Process of Weaning from Mechanical Ventilation

>

Phenotyping Asthma and COPD

>

In Utero Exposure to Organic Pollutants and Lung Function in the Offspring

>

New Lung Imaging Findings in Chronic Respiratory Diseases

>

Cigarette Smoke Exposure Alters Bacterial-Host Interactions in the Respiratory Tract to Promote Disease

>

Update in diagnosis and treatment of idiopathic pulmonary fibrosis

>

Artificial Intelligence in COPD: New Venues to Study a Complex Disease

>

The Case of Procalcitonin for Lower Respiratory Tract Infections

>

Tunneled pleural catheter in pleural effusion: To Whom? When? How?

>

Non-invasive Ventilation and High Flow Nasal Therapy in Acute Respiratory Failure: 2019 Novelties

>

Usefulness of Biological Clustering Patterns in Chronic Obstructive Pulmonary Disease

>

Diagnostic and Therapeutic Challenges for Patients with Idiopathic Pulmonary Fibrosis and Lung Cancer

>

Clinical Audits in Chronic Obstructive Pulmonary Disease: what for?

>

Prolonged Weaning and Respiratory Intensive Care Units. A Narrative Review

>

Cytomegalovirus Infection in Lung Transplantation: Importance of Specific Cellular Immune Response Assessment

>

New Therapeutic Pathways in Pulmonary Arterial Hypertension

>

Bronchiectasis and Other Chronic Airway Diseases: A Clinical-based Approach

>

Concurrence of Chronic Obstructive Pulmonary Disease and Sleep Apnoea: The Other Overlap Syndrome

>

Anti-Inflammatory Treatment of Asthma

>

Long-term non-invasive ventilation in pediatric neuromuscular diseases: challenges and advances

>

Thoracoscopy and talc pleurodesis for malignant pleural effusions

>

Molecular diagnostic techniques in respiratory infections

>

Phage therapy in mycobacteria

>

Obese Asthma Syndrome, Glucocorticoids, and Vitamin D: Mechanisms and Implications

>

The RICU during the COVID Pandemic

>

Double or Triple Therapy in Chronic Obstructive Pulmonary Disease

>

Current and Future Respiratory Medicine Challenges: Insights from a Barcelona Respiratory Network Foundation Retreat in Barcelona in 2017

>

Systematic Reviews on Pharmacological Treatment of Asthma and Chronic Obstructive Pulmonary Disease

>

Chronic Obstructive Pulmonary Disease: Lessons from the Important Treatment Trials

>

The Liver-Lung Vascular Connection